心臓除細動器市場：製品タイプ、患者タイプ、エンドユーザー別-2025-2030年の世界予測

心臓除細動器市場は、2023年に84億7,000万米ドルと評価され、2024年には91億2,000万米ドルに達すると予測され、CAGR 7.92%で成長し、2030年には144億5,000万米ドルに達すると予測されています。

心臓除細動器は、生命を脅かす心臓の不整脈、特に心室細動や心室頻拍の影響を受けた心臓に、治療量の電気エネルギーを供給するように設計された医療機器です。この機器は、特に病院や在宅のリスクのある患者に対して、緊急対応状況や長期的な患者管理の両方のために医療分野で不可欠です。最終用途は病院、病院前救急ユニット、個々の患者に及び、都市部と農村部の両方の医療環境で応用されています。この市場の成長に影響を与える主な要因には、心血管疾患の発生率の上昇、除細動技術の技術的進歩、心臓の健康に対する意識の高まりなどがあります。特に、公共環境における自動体外式除細動器（AED）の受け入れ拡大、医療ニーズが満たされていない新興市場への進出、リアルタイムのモニタリングとデータ収集のためのIoTの統合にビジネスチャンスが存在します。しかし、同市場は、厳しい規制当局の承認、高額な機器コスト、除細動器を効果的に使用するための専門的トレーニングの必要性などの課題に直面しています。また、急速な進歩に伴い技術が陳腐化する可能性もあり、研究開発への継続的な投資が必要となることも制限要因となっています。競争の激しいマーケットプレースでは技術革新が求められており、よりコンパクトで使いやすく、費用対効果の高いモデルの開発や、バッテリー寿命や接続機能の改善にチャンスが眠っています。除細動療法を予測し、パーソナライズするためのAIや機械学習の調査は、革命的なものとなる可能性があります。市場プレイヤーは、市場への浸透を高めるために、ヘルスケアプロバイダーや公衆衛生機関との提携に注力すべきです。除細動器市場の性質はダイナミックであり、有効性と患者の転帰を重視する価値ベースのヘルスケア提供への傾倒が見られます。持続的な成長には、イノベーションを促進しながら規制の変化や患者のニーズに対応し続けることが不可欠です。

市場力学：急速に進化する心臓除細動器市場の主要市場インサイトを公開

心臓除細動器市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業組織は十分な情報に基づいた投資決定、戦略的決定の精緻化、新たなビジネスチャンスの獲得を行うことができます。こうした動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 心臓不整脈および突然の心停止（SCA）の有病率の増加
  • 救急医療対応システムを改善するための政府の取り組み
  • 植え込み型除細動器（ICD）の採用拡大
• 市場抑制要因
  • 心臓除細動器に関する一般市民の認知度の低さ
• 市場機会
  • 心臓除細動器技術の継続的な進歩
  • 公共アクセス心臓除細動プログラムの拡大
• 市場の課題
  • 熟練した専門家の不足

ポーターの5つの力：心臓除細動器市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：心臓除細動器市場における外部からの影響の把握

外部マクロ環境要因は、心臓除細動器市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析心臓除細動器市場における競合情勢の把握

心臓除細動器市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス心臓除細動器市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、心臓除細動器市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨心臓除細動器市場における成功への道筋を描く

心臓除細動器市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 不整脈および突然心停止（SCA）症例の増加
    • 緊急医療対応システムの改善に向けた政府の取り組み
    • 植込み型除細動器（ICD）の採用増加
  • 抑制要因
    • 心臓除細動器に関する一般大衆の認知度は低い
  • 機会
    • 心臓除細動器技術の継続的な進歩
    • 公衆アクセス心臓除細動プログラムの拡大
  • 課題
    • 熟練した専門家の不足
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 心臓除細動器市場：製品別

• 植込み型除細動器
• 皮下植込み型除細動器
• 経静脈植込み型除細動器
• ウェアラブル除細動器

第7章 心臓除細動器市場患者タイプ別

• 成人用
• 小児科

第8章 心臓除細動器市場：エンドユーザー別

• クリニックと心臓センター
• 在宅ヘルスケア
• 病院

第9章 南北アメリカの心臓除細動器市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の心臓除細動器市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの心臓除細動器市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Abbott Laboratories
• AMI Italia S.r.l.
• Apex Medical Systems
• Baxter International Inc.
• Bexen Cardio
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• CU Medical Systems
• GE HealthCare Technologies Inc.
• Koninklijke Philips N.V.
• LivaNova PLC
• Mediana Co., Ltd.
• Medtonic PLC
• Metsis Medikal
• MicroPort Scientific Corporation
• Narang Medical Limited
• Nihon Kohden Corporation
• Progetti Srl
• Schiller AG
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Stryker Corporation
• Thermo Fisher Scientific Inc.
• Vivan Meditech
• ZOLL Medical Corporation by Asahi Kasei Corporation

LIST OF FIGURES

• FIGURE 1. CARDIAC DEFIBRILLATORS MARKET RESEARCH PROCESS
• FIGURE 2. CARDIAC DEFIBRILLATORS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. CARDIAC DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. CARDIAC DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CARDIAC DEFIBRILLATORS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. CARDIAC DEFIBRILLATORS MARKET DYNAMICS
• TABLE 7. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY WEARABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY ADULT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PEDIATRICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY CLINICS & CARDIAC CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL CARDIAC DEFIBRILLATORS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 22. AMERICAS CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 25. ARGENTINA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 28. BRAZIL CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 29. CANADA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. CANADA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 31. CANADA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. MEXICO CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 38. UNITED STATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 42. ASIA-PACIFIC CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 45. AUSTRALIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 46. CHINA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 47. CHINA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CHINA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. INDIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 50. INDIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 51. INDIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. INDONESIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 57. JAPAN CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. MALAYSIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. PHILIPPINES CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 66. SINGAPORE CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. SOUTH KOREA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 72. TAIWAN CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. THAILAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 78. VIETNAM CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. DENMARK CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 88. EGYPT CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. FINLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 94. FRANCE CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. GERMANY CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 100. ISRAEL CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. ITALY CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. ITALY CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 103. ITALY CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 106. NETHERLANDS CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 109. NIGERIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 112. NORWAY CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 113. POLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 114. POLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 115. POLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. QATAR CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. QATAR CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 118. QATAR CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 121. RUSSIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 124. SAUDI ARABIA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 127. SOUTH AFRICA CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 130. SPAIN CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 133. SWEDEN CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 136. SWITZERLAND CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 139. TURKEY CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 142. UNITED ARAB EMIRATES CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM CARDIAC DEFIBRILLATORS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM CARDIAC DEFIBRILLATORS MARKET SIZE, BY PATIENT TYPE, 2018-2030 (USD MILLION)
• TABLE 145. UNITED KINGDOM CARDIAC DEFIBRILLATORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. CARDIAC DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 147. CARDIAC DEFIBRILLATORS MARKET, FPNV POSITIONING MATRIX, 2023

The Cardiac Defibrillators Market was valued at USD 8.47 billion in 2023, expected to reach USD 9.12 billion in 2024, and is projected to grow at a CAGR of 7.92%, to USD 14.45 billion by 2030.

Cardiac defibrillators are medical devices designed to deliver a therapeutic dose of electrical energy to the heart affected by life-threatening cardiac dysrhythmias, specifically ventricular fibrillation and ventricular tachycardia. This equipment is vital within the medical field for both emergency response situations and long-term patient management, particularly in hospitals and for at-risk patients at home. The end-use scope spans hospitals, pre-hospital emergency units, and individual patients, with applications in both urban and rural medical settings. Key factors influencing growth in this market include rising incidences of cardiovascular diseases, technological advancements in defibrillation technology, and increasing awareness about heart health. Opportunities exist particularly in the growing acceptance of automated external defibrillators (AEDs) in public settings, expansion into emerging markets with unmet healthcare needs, and integration of IoT for real-time monitoring and data collection. However, the market faces challenges such as stringent regulatory approvals, high costs of devices, and the need for professional training to use defibrillators effectively. Limitations also stem from the potential for technology obsolescence as rapid advancements occur, requiring continuous investment in R&D. The competitive marketplace demands innovation, with opportunities lying in developing more compact, user-friendly, and cost-effective models, as well as in improving battery life and connectivity features. Research into AI and machine learning to predict and personalize defibrillation therapy could prove revolutionary. Market players should focus on partnerships with healthcare providers and public health organizations to enhance market penetration. The nature of the defibrillator market is dynamic, with a leaning towards value-based healthcare delivery, emphasizing effectiveness and patient outcomes. Staying attuned to regulatory changes and patient needs while fostering innovation will be essential for sustained growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Defibrillators Market

The Cardiac Defibrillators Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiac arrhythmias and sudden cardiac arrest (SCA) cases
  • Government initiatives to improve emergency medical response systems
  • Growing adoption of implantable cardioverter-defibrillators (ICDs)
• Market Restraints
  • Limited awareness among the general public about cardiac defibrillators
• Market Opportunities
  • Ongoing advancements in cardiac defibrillator technologies
  • Expansion of public access cardiac defibrillation programs
• Market Challenges
  • Limited availability of skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Defibrillators Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Defibrillators Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Defibrillators Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Defibrillators Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Defibrillators Market

A detailed market share analysis in the Cardiac Defibrillators Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Defibrillators Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Defibrillators Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Defibrillators Market

A strategic analysis of the Cardiac Defibrillators Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Defibrillators Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AMI Italia S.r.l., Apex Medical Systems, Baxter International Inc., Bexen Cardio, BIOTRONIK SE & Co. KG, Boston Scientific Corporation, CU Medical Systems, GE HealthCare Technologies Inc., Koninklijke Philips N.V., LivaNova PLC, Mediana Co., Ltd., Medtonic PLC, Metsis Medikal, MicroPort Scientific Corporation, Narang Medical Limited, Nihon Kohden Corporation, Progetti Srl, Schiller AG, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Stryker Corporation, Thermo Fisher Scientific Inc., Vivan Meditech, and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Defibrillators Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Implantable Cardioverter Defibrillators, Subcutaneous Implantable Cardioverter Defibrillators, Transvenous Implantable Cardioverter Defibrillators, and Wearable Cardioverter Defibrillators.
• Based on Patient Type, market is studied across Adult and Pediatrics.
• Based on End-user, market is studied across Clinics & Cardiac Centers, Home Healthcare, and Hospital.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiac arrhythmias and sudden cardiac arrest (SCA) cases
    • 5.1.1.2. Government initiatives to improve emergency medical response systems
    • 5.1.1.3. Growing adoption of implantable cardioverter-defibrillators (ICDs)
  • 5.1.2. Restraints
    • 5.1.2.1. Limited awareness among the general public about cardiac defibrillators
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in cardiac defibrillator technologies
    • 5.1.3.2. Expansion of public access cardiac defibrillation programs
  • 5.1.4. Challenges
    • 5.1.4.1. Limited availability of skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac Defibrillators Market, by Product

• 6.1. Introduction
• 6.2. Implantable Cardioverter Defibrillators
• 6.3. Subcutaneous Implantable Cardioverter Defibrillators
• 6.4. Transvenous Implantable Cardioverter Defibrillators
• 6.5. Wearable Cardioverter Defibrillators

7. Cardiac Defibrillators Market, by Patient Type

• 7.1. Introduction
• 7.2. Adult
• 7.3. Pediatrics

8. Cardiac Defibrillators Market, by End-user

• 8.1. Introduction
• 8.2. Clinics & Cardiac Centers
• 8.3. Home Healthcare
• 8.4. Hospital

9. Americas Cardiac Defibrillators Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Cardiac Defibrillators Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Cardiac Defibrillators Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. AMI Italia S.r.l.
• 3. Apex Medical Systems
• 4. Baxter International Inc.
• 5. Bexen Cardio
• 6. BIOTRONIK SE & Co. KG
• 7. Boston Scientific Corporation
• 8. CU Medical Systems
• 9. GE HealthCare Technologies Inc.
• 10. Koninklijke Philips N.V.
• 11. LivaNova PLC
• 12. Mediana Co., Ltd.
• 13. Medtonic PLC
• 14. Metsis Medikal
• 15. MicroPort Scientific Corporation
• 16. Narang Medical Limited
• 17. Nihon Kohden Corporation
• 18. Progetti Srl
• 19. Schiller AG
• 20. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• 21. Stryker Corporation
• 22. Thermo Fisher Scientific Inc.
• 23. Vivan Meditech
• 24. ZOLL Medical Corporation by Asahi Kasei Corporation